Glucosamine inhibits extracellular matrix accumulation in experimental diabetic nephropathy

INTRODUCTION: Glucosamine, the intermediate metabolite of the hexosamine biosynthesis pathway (HBP), is widely used as a supplementary drug in patients with osteoarthritis. However, its consequences in such patients concomitantly suffering from diabetic nephropathy is unknown. METHODS: The aim of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Teuma, Loic, Eshwaran, Rachana, Tawokam Fongang, Ulrich, Wieland, Johanna, Shao, Feng, Lagana, Maria Luisa, Wang, Yixin, Agaci, Ane, Hammes, Hans-Peter, Feng, Yuxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751334/
https://www.ncbi.nlm.nih.gov/pubmed/36532524
http://dx.doi.org/10.3389/fnut.2022.1048305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751334/
https://www.ncbi.nlm.nih.gov/pubmed/36532524
http://dx.doi.org/10.3389/fnut.2022.1048305

Ejemplares similares